Literature DB >> 19347845

Vaccination of mice with baculovirus-infected insect cells expressing antigenic proteins.

Kimberly R Jordan1, Fran Crawford, John W Kappler, Jill E Slansky.   

Abstract

Methods to induce antigen-specific immune responses in mice using insect cells infected with recombinant baculoviruses are described in this unit. Although this vaccine strategy has been used to generate both antibody and T cell responses, it has been more thoroughly characterized for the peptide-specific cytotoxic T cell responses. Nonspecific responses to the vaccine vehicle are controlled for by vaccinating with insect cells infected with baculoviruses encoding irrelevant antigens or no antigen. The baculovirus-infected insect cells alone are an effective immune adjuvant to elicit antigen-specific T cells. Overall, immune responses generated using this approach are similar to those generated by more conventional vaccine strategies. Copyright 2009 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347845      PMCID: PMC3343717          DOI: 10.1002/0471142735.im0215s85

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  14 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

3.  Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation.

Authors:  Julie M Curtsinger; Javier O Valenzuela; Pujya Agarwal; Debra Lins; Matthew F Mescher
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 4.  Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands.

Authors:  Frances Crawford; Kimberly R Jordan; Brian Stadinski; Yibing Wang; Eric Huseby; Philippa Marrack; Jill E Slansky; John W Kappler
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

5.  Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.

Authors:  Kimberly R Jordan; Rachel H McMahan; Jason Z Oh; Matthew R Pipeling; Drew M Pardoll; Ross M Kedl; John W Kappler; Jill E Slansky
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

6.  In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

Authors:  A Y Huang; A T Bruce; D M Pardoll; H I Levitsky
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

7.  Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex.

Authors:  J E Slansky; F M Rattis; L F Boyd; T Fahmy; E M Jaffee; J P Schneck; D H Margulies; D M Pardoll
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

8.  CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion.

Authors:  Peter Aichele; Heike Unsoeld; Marie Koschella; Oliver Schweier; Ulrich Kalinke; Smiljka Vucikuja
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

9.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  1 in total

1.  A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.

Authors:  Hyun-Jin Shin; Luis H Franco; Vidhya R Nair; Angela C Collins; Michael U Shiloh
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.